Green Thumb Industries Inc. (CSE:GTII) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 12
Canadian (TSX) Pharma Industry Analysis
UpdatedApr 18, 2024
DataAggregated Company Financials
Companies90
- 7D-3.6%
- 3M15.7%
- 1Y58.0%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 11%, driven by Green Thumb Industries declining 12%. Over the past 12 months, the industry was up 44%. Looking forward, earnings are forecast to grow by 65% annually.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 18 Apr 2024 | CA$24.2b | CA$12.0b | -CA$3,479,051,905.12 | 8.7x | -7x | 2x |
| Sat, 16 Mar 2024 | CA$19.2b | CA$11.9b | -CA$3,499,996,583.81 | 8.9x | -5.5x | 1.6x |
| Mon, 12 Feb 2024 | CA$23.3b | CA$11.9b | -CA$6,801,390,350.33 | 12.1x | -3.4x | 2x |
| Wed, 10 Jan 2024 | CA$19.3b | CA$12.3b | -CA$6,742,078,090.00 | 10x | -2.9x | 1.6x |
| Fri, 08 Dec 2023 | CA$19.7b | CA$12.4b | -CA$6,785,821,946.00 | 8.5x | -2.9x | 1.6x |
| Sun, 05 Nov 2023 | CA$16.1b | CA$12.4b | -CA$7,313,471,152.00 | 11.6x | -2.2x | 1.3x |
| Tue, 03 Oct 2023 | CA$20.0b | CA$12.4b | -CA$7,336,437,455.00 | 15.5x | -2.7x | 1.6x |
| Thu, 31 Aug 2023 | CA$15.5b | CA$12.9b | -CA$7,869,696,339.00 | 13.9x | -2x | 1.2x |
| Sat, 29 Jul 2023 | CA$14.3b | CA$13.2b | -CA$9,713,979,724.00 | 12.4x | -1.5x | 1.1x |
| Mon, 26 Jun 2023 | CA$14.7b | CA$13.1b | -CA$9,509,166,656.00 | 13.7x | -1.5x | 1.1x |
| Wed, 24 May 2023 | CA$15.3b | CA$13.3b | -CA$10,449,908,430.00 | 10x | -1.5x | 1.1x |
| Fri, 21 Apr 2023 | CA$15.0b | CA$13.3b | -CA$9,955,452,188.00 | 10.8x | -1.5x | 1.1x |
| Sun, 19 Mar 2023 | CA$18.1b | CA$13.9b | -CA$10,109,313,585.00 | 8.7x | -1.8x | 1.3x |
| Tue, 14 Feb 2023 | CA$19.3b | CA$13.5b | -CA$10,280,405,767.00 | 10x | -1.9x | 1.4x |
| Thu, 12 Jan 2023 | CA$19.9b | CA$13.5b | -CA$10,106,622,272.00 | 13.4x | -2x | 1.5x |
| Sat, 10 Dec 2022 | CA$26.4b | CA$13.7b | -CA$10,215,580,032.00 | 16.8x | -2.6x | 1.9x |
| Mon, 07 Nov 2022 | CA$28.2b | CA$13.4b | -CA$9,408,055,527.00 | 12.1x | -3x | 2.1x |
| Wed, 05 Oct 2022 | CA$25.6b | CA$13.3b | -CA$9,380,455,895.00 | 10.4x | -2.7x | 1.9x |
| Fri, 02 Sep 2022 | CA$31.7b | CA$13.1b | -CA$8,846,764,294.00 | 13.8x | -3.6x | 2.4x |
| Sun, 31 Jul 2022 | CA$27.7b | CA$12.2b | -CA$5,843,554,758.00 | 12.8x | -4.7x | 2.3x |
| Tue, 28 Jun 2022 | CA$27.6b | CA$12.2b | -CA$5,784,650,065.00 | 8.4x | -4.8x | 2.3x |
| Thu, 26 May 2022 | CA$32.0b | CA$12.1b | -CA$5,610,815,771.00 | 10x | -5.7x | 2.7x |
| Sat, 23 Apr 2022 | CA$38.3b | CA$11.6b | -CA$4,730,323,456.00 | 11.3x | -8.1x | 3.3x |
| Mon, 21 Mar 2022 | CA$43.4b | CA$11.0b | -CA$4,714,127,355.00 | 14.2x | -9.2x | 4x |
| Wed, 16 Feb 2022 | CA$53.1b | CA$10.9b | -CA$3,881,577,009.00 | 14.6x | -13.7x | 4.9x |
| Fri, 14 Jan 2022 | CA$52.2b | CA$10.7b | -CA$4,905,695,337.00 | 12.8x | -10.6x | 4.9x |
| Sun, 12 Dec 2021 | CA$55.3b | CA$10.9b | -CA$4,829,392,302.00 | 14.6x | -11.5x | 5.1x |
| Tue, 09 Nov 2021 | CA$62.2b | CA$9.7b | -CA$4,665,284,471.00 | 17x | -13.3x | 6.4x |
| Thu, 07 Oct 2021 | CA$66.4b | CA$10.3b | -CA$4,891,289,673.00 | 19x | -13.6x | 6.4x |
| Sat, 04 Sep 2021 | CA$69.2b | CA$10.2b | -CA$6,616,236,433.27 | 23.3x | -10.5x | 6.8x |
| Mon, 02 Aug 2021 | CA$74.4b | CA$10.2b | -CA$6,616,236,433.27 | 25.2x | -11.3x | 7.3x |
| Thu, 06 May 2021 | CA$84.2b | CA$8.9b | -CA$7,574,008,271.21 | 25.7x | -11.1x | 9.5x |
Price to Earnings Ratio
-11.1x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.2x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Canadian Pharma compare with similar industries?
| CA Market | -2.09% | |
| Healthcare | -3.13% | |
| Pharma | -3.55% | |
| Pharma | -3.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CL Cresco Labs | CA$3.02 | 2.4% +CA$24.3m | 51.0% | PS1x | |
| GRIN Grown Rogue International | CA$0.93 | 12.0% +CA$23.2m | 416.7% | PS6.7x | |
| AYR.A Ayr Wellness | CA$3.76 | 3.9% +CA$15.8m | 342.4% | PS0.6x | |
| CPH Cipher Pharmaceuticals | CA$8.82 | 5.6% +CA$12.3m | 159.4% | PE7.6x | |
| FFNT 4Front Ventures | CA$0.14 | 3.7% +CA$4.6m | -37.8% | PS1x |